Health and science

CDC’s numbers reignite debate on youth vaping in the U.S.

22nd April 2016 - News analysis |

New numbers on U.S. youth tobacco use from the Centers for Disease Control and Prevention (CDC) have caused consternation on both sides of the e-cigarette debate, focused on whether growing numbers of young vapers represent an achievement or a failure in public health.

E-cig science: do meta-analyses really matter?

5th April 2016 - News analysis |

In the past year or so, scientists have conducted several systematic reviews that aim to analyse research evidence in order to find whether e-cigs help people quit smoking. The issue addressed by studies like these (which can also be known as meta-analyses) is, of course, one of the primary public-health and policy questions about the devices. But how much value should we place on their findings?

U.S. state and federal regulation: what to expect in 2016

10th February 2016 - Regulatory reports , Topic regulatory reports |

More vapour-related bills were introduced during the 2015 state legislative sessions than ever before, and ECigIntelligence expects even more vapour regulation to be proposed during the 2016 regular session. This report looks at the current regulatory situation across the U.S. in key areas such as manufacturing, labelling, advertising and marketing, public place usage, youth access and taxation, and forecasts the regulatory trends for 2016.

Updated: Germany’s draft TPD plans and beyond

19th January 2016 - Country regulatory reports , Regulatory reports |

Introduction • Regulatory landscape • Current national regulatory framework • National regulatory framework post-TPD • Age restrictions • Product restrictions • Ingredients • Labelling and packaging • Product notification • Annual reporting • Vigilance • Retailing • Public usage • North Rhine-Westphalia • Bavaria • Baden-Württemberg • Lower Saxony • Hesse • Public usage: an inconsistent future? • Advertising and marketing • Taxation • Enforcement • Case law: e-cigarettes as medical products • Case law: e-cigarettes as tobacco products • Case law: tobacco advertising restrictions • The missing pieces from the TPD jigsaw • Graphic: how German e-cigarette regulation will change

CDC report on kids and e-cig advertising may be flawed

12th January 2016 - Marketing & retailing , News analysis |

As the advertising spend of U.S. e-cigarette suppliers escalates, they are continuing to use themes such as independence, rebellion and sex to sell their products – and their advertisements are prompting interest among the many young people who see them, according to a critical report from the Centers for Disease Control and Prevention (CDC). Yet some of the data relied upon by the CDC appears to raise questions of accuracy and relevance.

Big Tobacco encouraged by research on heat-not-burn

7th December 2015 - News analysis |

Are big tobacco companies starting to favour heat-not-burn technology over e-cigarettes? While none has shown any signs of overtly stepping away from e-cigs, and such a move is unlikely, much enthusiasm and investment within the tobacco industry seems to be going toward heat-not-burn.

Flavour important for under-age U.S. vapers

29th November 2015 - News analysis |

Most underage vapers in America prefer the taste of mint, clove, fruit, chocolate, or alcohol to plain nicotine juice. More than 80 per cent of the 1,450 teenage respondents who had experimented with e-cigs said that their first ever puff was flavoured. The only products more likely to be flavoured when teens first tried them were hookahs (88.7%), according to » Continue Reading.

Dual users experience significantly lower CO levels

29th November 2015 - News analysis |

It sounds like common sense: if people smoke fewer conventional cigarettes because they are using e-cigs as well, you would expect them to be exposed to fewer harmful substances. And that’s what a study has found after examining the effects on a group of smokers who were trying to quit by using e-cigs, although other research suggests that it may » Continue Reading.

Hungary regulatory report: an end to mandatory pharma licensing

13th November 2015 - Country market reports , Country regulatory reports , Market reports , Regulatory reports |

Hungary’s transposition of the EU Tobacco Products Directive will do away with the current mandatory pharmaceutical licensing requirement for e-cigarettes – which has resulted in no nicotine-containing products being legal in the country – and allow them to be sold as consumer products. As this great change approaches, our in-depth report on Hungary includes: Regulatory landscape • Current national regulatory framework • Age restrictions • Packaging and product restrictions • Notification requirements • Retailing restrictions (including cross-border and distance sales) • Public usage • Advertising and marketing restrictions • Taxation • Case law • Enforcement • The missing pieces of the TPD jigsaw • Graphic: how Hungarian e-cigarette regulation will change

PMTAs: the road to FDA approval for e-cigarette products

12th November 2015 - Regulatory reports , Topic regulatory reports |

Executive summary • Introduction • Why an electronic nicotine delivery system (ENDS) product requires a PMTA: distinction among ENDS products, components/parts, and accessories; three pathways to market approval; concerns about the grandfather date • Guidance for industry: information on premarket tobacco product applications (PMTA) and the submission process • Public health considerations: scientific evidence, comparative analysis, voluntary restrictions on sale and distribution, nicotine exposure warnings, child-resistant packaging, alternatives to new scientific studies, government-sponsored databases, non-U.S. randomised controlled clinical trials, literature reviews or reports • FDA enforcement for manufacturers and retailers: enforcement limited to finished tobacco products; independent vapour shops considered as tobacco product manufacturers • Appendix 1: definitions • Appendix 2: submitting a PMTA